Gamitaeeumjowee-tang for Weight Loss in Overweight and Obese Women with Polycystic Ovary Syndrome: A Retrospective Chart Review |
Min-jeong Park
(Nubebe Korean Medical Clinic Gangnam Center)
Eunjoo Kim (Nubebe Mibyeong Research Institute) Ji-Myung Ok (Nubebe Korean Medical Clinic Gangnam Center) Ka-Hye Choi (Nubebe Korean Medical Clinic Hongdae Center) Young-Woo Lim (Nubebe Mibyeong Research Institute) |
1 | Min WG. Polycystic ovary syndrome. J Korean Obstet Gynecol. 2008 ; 51(8) : 805-19. |
2 | Korean Society of Obstetrics and Gynecology. Gynecology. 5th ed. Seoul : Korea Medical Book Publishing Company (KOMB). 2015 : 488. |
3 | Byun EG, Kim HJ, Oh JY, Hong YS, Sung YA. The prevalence of polycystic ovary syndrome in college students from Seoul. Journal of Korean Endocrine Society. 2005 ; 20(2) : 120-6. DOI |
4 | Health Insurance Review & Assessment Service. Healthcare Bigdata Hub [Internet]. 2022 [cited 2022 Oct 26]. Available from: https://opendata.hira.or.kr/op/opc/olap4thDsInfo.do. |
5 | Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf). 2000 ; 52 : 595-600. DOI |
6 | Kim JJ, Hwang KR, Choi YM, Moon SY, Chae SJ, Park CW, et al. Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome. Fertil Steril. 2014 ; 101(5) : 1424-30. DOI |
7 | Thmas MB, Petra H, Martin OW, Stephen F. Obestiy and polycystic overy syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019 ; 13 : 1179558119874042. |
8 | Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1995 ; 80 : 2586-93. DOI |
9 | Moran L, Norman RJ. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004 ; 18(5) : 719-36. DOI |
10 | Mamaru AA, Arul E, Anju EJ, Allison MH, Helena JT, Wendy JB, et al. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Human Reproduction. 2022 ; 37(1) : 129-41. |
11 | Linden HA, Naessen S, Stridsberg M, Bystrom B, Holte J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol. 2004 ; 19 : 79-87. DOI |
12 | Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, et al. Basal metabolic rate is decreased in womenwith polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertil Steril. 2009 ; 92 : 250-5. DOI |
13 | Robinson S, Chan SP, Spacey S, Anyaoku V, Johnston DG, Franks S. Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol. 1992 ; 36 : 537-43. DOI |
14 | Hellas C, Luca C, Rossella EN. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endotrinl Metab. 2020 ; 105(8) : e2695-709. DOI |
15 | Cho YJ, Lee YJ, Ahn YT, Kang ES, Kim HJ, Hong DH, et al. A review of the clinical study trends on Korean medicine treatment for polycystic ovary syndrome. J Korean Obstet Gynecol. 2022 ; 35(2) : 87-105. |
16 | Park SH, Lee JM, Lee CH, Jang JB, Hwang DS. Analysis of the characteristics and treatment of polycystic ovary syndrome patients in a Korean medicine hospital. J Korean Obstet Gynecol. 2019 ; 32(1) : 37-47. |
17 | Korea Institute of Drug Safety & Risk Reaction Management. Adverse Drug Assessment Report. 1st ed. Seoul : Korea Institute of Drug Safety & Risk Management. 2013 : 60-3. |
18 | Shin HG, Bae JY, Ji YG, Ahn HI, Yoon YH, Kim NK. A case series of polycystic ovary syndrome with improved hyperandrogenism treated with Korean medicine. J Korean Obstet Gynecol. 2021 ; 34(3) : 175-91. DOI |
19 | Kim DH. A case study on obese patient with oligomenorrhea and polycystic ovary. J Korean Med Obes Res. 2008 ; 8(1) : 101-8. |
20 | Lee JS. A case study on infertility with obesity and polycystic ovary. J Korean Med Obes Res. 2005 ; 5(1) : 157-63. |
21 | National Cancer Institute, National Institute of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 [Internet]. 2009 [cited 2009 May 29]. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf. |
22 | Korea Institute of Drug Safety & Risk Management. Terminology guide for reporting adverse drug reactions. Seoul : Korea Institute of Drug Safety & Risk Management. 2014 : 1-6. |
23 | Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, et al. Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015 ; 100 : 4048-58. DOI |
24 | European Society of Human Reproduction and Embryology; The Thessaloniki, and ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008 ; 23 : 462-77. DOI |
25 | Dapas M, Lin FTJ, Nadkarni GN, Sick R, Legro RS, Urbanek M, et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. PLoS Med. 2020 ; 17(6) : e1003132. |
26 | Park YJ, Cominguez DC, Kim HJ, Jin JS, Koh DJ, Kim SY, et al. Therapeutic effects of Gambi-jung for the treatment of obesity. Biomedicine & Pharmacotherapy. 2021; 141 : 111838. |
27 | Kang EY, Park YJ, Kim MJ, Park YB. A study on factors associated with weight loss by 'Gamitaeeumjowee-tang'. J Korean Med Obes Res. 2017 ; 17(2) : 68-72. DOI |
28 | Lee A, Lee DY, Kim MJ, Lee HS, Choi KH, Kim SY, et al. Gamitaeeumjowee-tang for weight loss in diabetic patients: a retrospective chart review. J Korean Med. 2021 ; 42(1) : 46-57. DOI |
29 | Yoon NR, Yoo YJ, Kim MJ, Kim SY, Lim YW, Lim HH, et al. Analysis of adverse events in weight loss program in combination with 'Gamitaeeumjowee-tang' and low-calorie diet. J Korean Med Obes Res. 2018 ; 18(1) : 1-9. DOI |
30 | Javed Z, Papageorgiou M, Dexhmukh H, Rigby AS, Qamar U, Abbas J, et al. Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study. Clin Endocrinol (Oxf). 2019 ; 90(6) : 805-13. DOI |
31 | Ma RL, Deng Y, Wang YF, Zhu SY, Ding XS, Sun AJ. Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome. Chin Med J (Engl). 2021 ; 134(23) : 2882-9. DOI |
32 | Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A, Fallahzadeh H, Nadjaradeh A. Effects of dietary approach to stop hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. J Hum Nutr Diet. 2017 ; 30(3) : 275-83. DOI |
33 | Jo GW, Ok JM, Kim SY, Lim YW. Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT. J Korean Med. 2017 ; 38(3) : 170-84. DOI |
34 | Christensen P, Bliddal H, Riecke BF, Leeds AR, Astrup A, Christensen R. Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial. Obes. 2011 ; 1(1) : 31-40. |